Announcement on the Results of Issuance of the 2025 Phase I Science and Technology Innovation Bonds

About this update from North China Pharmaceutical Company Ltd. Class A

Announcement on the Results of Issuance of the 2025 Phase I Science and Technology Innovation BondsThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for North China Pharmaceutical Company Ltd. Class A